Allspring Global Investments
RXRX icon

Allspring Global Investments’s Recursion Pharmaceuticals RXRX Stock Holding History

Allspring Global Investments’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,758
Closed -$24.8K – 2290
2024
Q3 		$24.8K Buy
+3,758
New +$26.9K ﹤0.01% 1962
2023
Q4 		– Sell
-10,123
Closed -$77.4K – 2660
2023
Q3 		$77.4K Buy
10,123
+2,050
+25% +$20.5K ﹤0.01% 2098
2023
Q2 		$60.3K Buy
8,073
+6,615
+454% +$46.3K ﹤0.01% 2238
2023
Q1 		$9.72K Buy
1,458
+722
+98% +$5.73K ﹤0.01% 2595
2022
Q4 		$5.67K Sell
736
-17
-2% -$167 ﹤0.01% 2774
2022
Q3 		$8K Buy
+753
New +$7.63K ﹤0.01% 2752

Other funds holding RXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Allspring Global Investments's RXRX Position: Q4 2024 in Review

Allspring Global Investments sold out of Recursion Pharmaceuticals (RXRX) in Q4 2024, closing a stake of 3,758 shares — an estimated $24.8K sold.

Allspring Global Investments first reported a position in RXRX in Q3 2022 and held it in 6 quarters. The position peaked at $77.4K in Q3 2023. 316 funds tracked by Wall St. Rank hold RXRX as of Q4 2024.

  • Allspring Global Investments reported no remaining Recursion Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 3,758 Recursion Pharmaceuticals shares in Q4 2024, an estimated $24.8K.
  • Allspring Global Investments first reported a position in Recursion Pharmaceuticals in Q3 2022 and held it in 6 quarters.
  • Allspring Global Investments's Recursion Pharmaceuticals position peaked at $77.4K in Q3 2023.
  • 316 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.